The US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2021-2025 Edition)
Scope of the Report
The report titled “The US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2021-2025 Edition)”, provides an in depth analysis of the US drug eluting sinus stent (DESS) market by value. The report also provides a detailed analysis of the US sinus surgery market by sinusitis patients, chronic sinusitis patients, number of ENT eligible patients, number of procedures, etc. The report also provides an analysis of the US Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD) market by Value and by number of procedures.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the US drug eluting sinus stent (DESS) market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The US drug eluting sinus stent (DESS) market is concentrated with few major market players operating in the region. The key players of the drug eluting sinus stent (DESS) market are Intersect ENT, Inc., Medtronic plc, Stryker Corporation (Entellus Medical, Inc.), and Johnson & Johnson (Acclarent, Inc.) are also profiled with their financial information and respective business strategies.
Country Coverage
Sinusitis can be divided into Acute Sinusitis, Recurrent Acute Rhinosinusitis (RARS) and chronic Rhinosinusitis (CRS), on the basis of the duration of the episode of sinusitis and its severity. The treatment options for the sinusitis can be over-the-counter treatment, medical management and surgery. The OTC treatment includes decongestants, antihistamines, pain relievers and nasal irrigation. Medical management includes antibiotics and oral and nasal steroids. The sinus surgeries are mainly of two types: Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD).
The US drug eluting sinus stent (DESS) market has increased significantly during the years 2018-2020, and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The drug eluting sinus stent (DESS) market is expected to increase due to surging healthcare expenditure, increasing prevalence of sinus related disorders, growing treatment in physician’s office, limitations of FESS, favorable government initiatives for promoting the use of sinus stents, etc. Yet the market faces some challenges such as economic slowdown, high cost involved, use of oral steroids and packing material, etc.
The report titled “The US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2021-2025 Edition)”, provides an in depth analysis of the US drug eluting sinus stent (DESS) market by value. The report also provides a detailed analysis of the US sinus surgery market by sinusitis patients, chronic sinusitis patients, number of ENT eligible patients, number of procedures, etc. The report also provides an analysis of the US Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD) market by Value and by number of procedures.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the US drug eluting sinus stent (DESS) market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The US drug eluting sinus stent (DESS) market is concentrated with few major market players operating in the region. The key players of the drug eluting sinus stent (DESS) market are Intersect ENT, Inc., Medtronic plc, Stryker Corporation (Entellus Medical, Inc.), and Johnson & Johnson (Acclarent, Inc.) are also profiled with their financial information and respective business strategies.
Country Coverage
- The US
- Intersect ENT, Inc.
- Medtronic plc
- Stryker Corporation (Entellus Medical, Inc.)
- Johnson & Johnson (Acclarent, Inc.)
Sinusitis can be divided into Acute Sinusitis, Recurrent Acute Rhinosinusitis (RARS) and chronic Rhinosinusitis (CRS), on the basis of the duration of the episode of sinusitis and its severity. The treatment options for the sinusitis can be over-the-counter treatment, medical management and surgery. The OTC treatment includes decongestants, antihistamines, pain relievers and nasal irrigation. Medical management includes antibiotics and oral and nasal steroids. The sinus surgeries are mainly of two types: Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD).
The US drug eluting sinus stent (DESS) market has increased significantly during the years 2018-2020, and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The drug eluting sinus stent (DESS) market is expected to increase due to surging healthcare expenditure, increasing prevalence of sinus related disorders, growing treatment in physician’s office, limitations of FESS, favorable government initiatives for promoting the use of sinus stents, etc. Yet the market faces some challenges such as economic slowdown, high cost involved, use of oral steroids and packing material, etc.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Sinus: An Overview
2.1.1 Types of Sinus
2.2 Sinusitis: An Overview
2.2.1 Types of Sinusitis
2.2.2 Treatment Options for Sinusitis
2.3 Drug Eluting Sinus Stent (DESS): An Overview
3. THE US MARKET ANALYSIS
3.1 The US Sinus Surgery Market: An Analysis
3.1.1 The US Sinus Surgery Market by Sinusitis Patients
3.1.2 The US Sinus Surgery Market by Chronic Sinusitis Patients
3.1.3 The US Sinus Surgery Market by Number of ENT Eligible Patients
3.1.4 The US Sinus Surgery Market by Surgical and Non Surgical ENT Eligible Patients
3.1.5 The US Sinus Surgery Market by Number of Procedures
3.1.6 The US Sinus Surgery Market Number of Procedures by Segments (Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD)
3.2 The US Functional Endoscopic Sinus Surgery (FESS) Market: An Analysis
3.2.1 The US Functional Endoscopic Sinus Surgery (FESS) Market by Value
3.2.2 The US Functional Endoscopic Sinus Surgery (FESS) Market by Number of Procedures
3.3 The US Balloon Sinus Dilation (BSD) Market: An Analysis
3.3.1 The US Balloon Sinus Dilation (BSD) Market by Value
3.3.2 The US Balloon Sinus Dilation (BSD) Market by Number of Procedures
3.3.3 The US Balloon Sinus Dilation (BSD) Market by Segments (operating room (OR) and Office)
3.3.4 The US Operating Room (OR) Balloon Sinus Dilation (BSD) Market by Value and by Number of Procedures
3.3.5 The US Office Balloon Sinus Dilation (BSD) Market by Value and by Number of Procedures
3.4 The US Drug Eluting Sinus Stent (DESS) Market: An Analysis
3.4.1 The US Drug Eluting Sinus Stent (DESS) Market by Value
4. MARKET DYNAMICS
4.1 Growth Driver
4.1.1 Surging Healthcare Expenditure
4.1.2 Increasing Prevalence of Sinus Related Disorders
4.1.3 Growing Treatment in Physician’s Office
4.1.4 Limitations of FESS
4.1.5 Favorable Government Initiatives for Promoting the Use of Sinus Stents
4.2 Challenges
4.2.1 Economic Slowdown
4.2.2 High Cost Involved
4.2.3 Use of Oral Steroids and Packing Material
4.3 Market Trends
4.3.1 Introduction of Innovative Techniques in Sinus Surgery
4.3.2 Increasing Awareness among Patients towards the Chronic Sinusitis and Sinus Surgery
4.3.3 Rising Popularity of Minimally Invasive Surgeries
4.3.4 Shift from FESS to BSD
5. COMPETITIVE LANDSCAPE
5.1 The US Drug Eluting Sinus Stent (DESS) Market Players: A Financial Comparison
5.2 The US Drug Eluting Sinus Stent (DESS) Market Players by Products and Services
6. COMPANY PROFILES
6.1 Intersect ENT, Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Medtronic plc
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Stryker Corporation (Entellus Medical, Inc.)
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
6.4 Johnson & Johnson (Acclarent, Inc.)
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategy
2. INTRODUCTION
2.1 Sinus: An Overview
2.1.1 Types of Sinus
2.2 Sinusitis: An Overview
2.2.1 Types of Sinusitis
2.2.2 Treatment Options for Sinusitis
2.3 Drug Eluting Sinus Stent (DESS): An Overview
3. THE US MARKET ANALYSIS
3.1 The US Sinus Surgery Market: An Analysis
3.1.1 The US Sinus Surgery Market by Sinusitis Patients
3.1.2 The US Sinus Surgery Market by Chronic Sinusitis Patients
3.1.3 The US Sinus Surgery Market by Number of ENT Eligible Patients
3.1.4 The US Sinus Surgery Market by Surgical and Non Surgical ENT Eligible Patients
3.1.5 The US Sinus Surgery Market by Number of Procedures
3.1.6 The US Sinus Surgery Market Number of Procedures by Segments (Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD)
3.2 The US Functional Endoscopic Sinus Surgery (FESS) Market: An Analysis
3.2.1 The US Functional Endoscopic Sinus Surgery (FESS) Market by Value
3.2.2 The US Functional Endoscopic Sinus Surgery (FESS) Market by Number of Procedures
3.3 The US Balloon Sinus Dilation (BSD) Market: An Analysis
3.3.1 The US Balloon Sinus Dilation (BSD) Market by Value
3.3.2 The US Balloon Sinus Dilation (BSD) Market by Number of Procedures
3.3.3 The US Balloon Sinus Dilation (BSD) Market by Segments (operating room (OR) and Office)
3.3.4 The US Operating Room (OR) Balloon Sinus Dilation (BSD) Market by Value and by Number of Procedures
3.3.5 The US Office Balloon Sinus Dilation (BSD) Market by Value and by Number of Procedures
3.4 The US Drug Eluting Sinus Stent (DESS) Market: An Analysis
3.4.1 The US Drug Eluting Sinus Stent (DESS) Market by Value
4. MARKET DYNAMICS
4.1 Growth Driver
4.1.1 Surging Healthcare Expenditure
4.1.2 Increasing Prevalence of Sinus Related Disorders
4.1.3 Growing Treatment in Physician’s Office
4.1.4 Limitations of FESS
4.1.5 Favorable Government Initiatives for Promoting the Use of Sinus Stents
4.2 Challenges
4.2.1 Economic Slowdown
4.2.2 High Cost Involved
4.2.3 Use of Oral Steroids and Packing Material
4.3 Market Trends
4.3.1 Introduction of Innovative Techniques in Sinus Surgery
4.3.2 Increasing Awareness among Patients towards the Chronic Sinusitis and Sinus Surgery
4.3.3 Rising Popularity of Minimally Invasive Surgeries
4.3.4 Shift from FESS to BSD
5. COMPETITIVE LANDSCAPE
5.1 The US Drug Eluting Sinus Stent (DESS) Market Players: A Financial Comparison
5.2 The US Drug Eluting Sinus Stent (DESS) Market Players by Products and Services
6. COMPANY PROFILES
6.1 Intersect ENT, Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Medtronic plc
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Stryker Corporation (Entellus Medical, Inc.)
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
6.4 Johnson & Johnson (Acclarent, Inc.)
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Types of Sinuses
Figure 2: Types of Sinusitis
Figure 3: Treatment Options for Sinusitis
Figure 4: The US Sinus Surgery Market by Sinusitis Patients; 2017-2020 (Million)
Figure 5: The US Sinus Surgery Market by Sinusitis Patients; 2021-2025 (Million)
Figure 6: The US Sinus Surgery Market by Chronic Sinusitis Patients; 2017-2020 (Million)
Figure 7: The US Sinus Surgery Market by Chronic Sinusitis Patients; 2021-2025 (Million)
Figure 8: The US Sinus Surgery Market by Number of ENT Eligible Patients; 2017-2020 (Million)
Figure 9: The US Sinus Surgery Market by Number of ENT Eligible Patients; 2021-2025 (Million)
Figure 10: The US Sinus Surgery Market by Surgical and Non Surgical ENT Eligible Patients; 2017-2025 (Million)
Figure 11: The US Sinus Surgery Market by Number of Procedures; 2017-2020 (Million)
Figure 12: The US Sinus Surgery Market by Number of Procedures; 2021-2025 (Million)
Figure 13: The US Sinus Surgery Market Number of Procedures by Segments; 2020 (Percentage, %)
Figure 14: The US Functional Endoscopic Sinus Surgery (FESS) Market by Value; 2018-2020 (US$ Million)
Figure 15: The US Functional Endoscopic Sinus Surgery (FESS) Market by Value; 2021-2025 (US$ Million)
Figure 16: The US Functional Endoscopic Sinus Surgery (FESS) Market by Number of Procedures; 2017-2020 (Thousand)
Figure 17: The US Functional Endoscopic Sinus Surgery (FESS) Market by Number of Procedures; 2021-2025 (Thousand)
Figure 18: The US Balloon Sinus Dilation (BSD) Market by Value; 2018-2020 (US$ Million)
Figure 19: The US Balloon Sinus Dilation (BSD) Market by Value; 2021-2025 (US$ Million)
Figure 20: The US Balloon Sinus Dilation (BSD) Market by Number of Procedures; 2017-2020 (Thousand)
Figure 21: The US Balloon Sinus Dilation (BSD) Market by Number of Procedures; 2021-2025 (Thousand)
Figure 22: The US BSD Market Value by Segments; 2020 (Percentage, %)
Figure 23: The US BSD Market Number of Procedures by Segments; 2020 (Percentage, %)
Figure 24: The US Operating Room (OR) BSD Market by Value; 2018-2025 (US$ Million)
Figure 25: The US Operating Room (OR) BSD Market by Number of Procedures; 2018-2025 (Thousand)
Figure 26: The US Office BSD Market by Value; 2018-2025 (US$ Million)
Figure 27: The US Office BSD Market by Number of Procedures; 2018-2025 (Thousand)
Figure 28: The US Drug Eluting Sinus Stent (DESS) Market by Value; 2018-2020 (US$ Million)
Figure 29: The US Drug Eluting Sinus Stent (DESS) by Value; 2021-2025 (US$ Million)
Figure 30: The US Health Expenditure; 2014-2020 (US$ Trillion)
Figure 31: The US Real GDP Growth; 2019-2021 (Percentage, %)
Figure 32: Intersect ENT, Inc. Revenue; 2015-2019 (US$ Million)
Figure 33: Intersect ENT, Inc. Revenue by Products; 2019 (Percentage, %)
Figure 34: Medtronic plc Net Sales; 2015-2019 (US$ Billion)
Figure 35: Medtronic plc Net Sales by Segments; 2020 (Percentage, %)
Figure 36: Medtronic plc Net Sales by Region; 2020 (Percentage, %)
Figure 37: Stryker Corporation Net Sales; 2016-2020 (US$ Billion)
Figure 38: Stryker Corporation Net Sales by Segments; 2020 (Percentage, %)
Figure 39: Stryker Corporation Net Sales by Region; 2020 (Percentage, %)
Figure 40: Johnson & Johnson Sales; 2016-2020 (US$ Billion)
Figure 41: Johnson & Johnson Sales by Segments; 2020 (Percentage, %)
Figure 42: Johnson & Johnson Sales by Region; 2020 (Percentage, %)
Table 1: The US Drug Eluting Sinus Stent (DESS) Market Players: A Financial Comparison; 2019/2020
Table 2: The US Drug Eluting Sinus Stent (DESS) Market Players by Products and Services
Figure 1: Types of Sinuses
Figure 2: Types of Sinusitis
Figure 3: Treatment Options for Sinusitis
Figure 4: The US Sinus Surgery Market by Sinusitis Patients; 2017-2020 (Million)
Figure 5: The US Sinus Surgery Market by Sinusitis Patients; 2021-2025 (Million)
Figure 6: The US Sinus Surgery Market by Chronic Sinusitis Patients; 2017-2020 (Million)
Figure 7: The US Sinus Surgery Market by Chronic Sinusitis Patients; 2021-2025 (Million)
Figure 8: The US Sinus Surgery Market by Number of ENT Eligible Patients; 2017-2020 (Million)
Figure 9: The US Sinus Surgery Market by Number of ENT Eligible Patients; 2021-2025 (Million)
Figure 10: The US Sinus Surgery Market by Surgical and Non Surgical ENT Eligible Patients; 2017-2025 (Million)
Figure 11: The US Sinus Surgery Market by Number of Procedures; 2017-2020 (Million)
Figure 12: The US Sinus Surgery Market by Number of Procedures; 2021-2025 (Million)
Figure 13: The US Sinus Surgery Market Number of Procedures by Segments; 2020 (Percentage, %)
Figure 14: The US Functional Endoscopic Sinus Surgery (FESS) Market by Value; 2018-2020 (US$ Million)
Figure 15: The US Functional Endoscopic Sinus Surgery (FESS) Market by Value; 2021-2025 (US$ Million)
Figure 16: The US Functional Endoscopic Sinus Surgery (FESS) Market by Number of Procedures; 2017-2020 (Thousand)
Figure 17: The US Functional Endoscopic Sinus Surgery (FESS) Market by Number of Procedures; 2021-2025 (Thousand)
Figure 18: The US Balloon Sinus Dilation (BSD) Market by Value; 2018-2020 (US$ Million)
Figure 19: The US Balloon Sinus Dilation (BSD) Market by Value; 2021-2025 (US$ Million)
Figure 20: The US Balloon Sinus Dilation (BSD) Market by Number of Procedures; 2017-2020 (Thousand)
Figure 21: The US Balloon Sinus Dilation (BSD) Market by Number of Procedures; 2021-2025 (Thousand)
Figure 22: The US BSD Market Value by Segments; 2020 (Percentage, %)
Figure 23: The US BSD Market Number of Procedures by Segments; 2020 (Percentage, %)
Figure 24: The US Operating Room (OR) BSD Market by Value; 2018-2025 (US$ Million)
Figure 25: The US Operating Room (OR) BSD Market by Number of Procedures; 2018-2025 (Thousand)
Figure 26: The US Office BSD Market by Value; 2018-2025 (US$ Million)
Figure 27: The US Office BSD Market by Number of Procedures; 2018-2025 (Thousand)
Figure 28: The US Drug Eluting Sinus Stent (DESS) Market by Value; 2018-2020 (US$ Million)
Figure 29: The US Drug Eluting Sinus Stent (DESS) by Value; 2021-2025 (US$ Million)
Figure 30: The US Health Expenditure; 2014-2020 (US$ Trillion)
Figure 31: The US Real GDP Growth; 2019-2021 (Percentage, %)
Figure 32: Intersect ENT, Inc. Revenue; 2015-2019 (US$ Million)
Figure 33: Intersect ENT, Inc. Revenue by Products; 2019 (Percentage, %)
Figure 34: Medtronic plc Net Sales; 2015-2019 (US$ Billion)
Figure 35: Medtronic plc Net Sales by Segments; 2020 (Percentage, %)
Figure 36: Medtronic plc Net Sales by Region; 2020 (Percentage, %)
Figure 37: Stryker Corporation Net Sales; 2016-2020 (US$ Billion)
Figure 38: Stryker Corporation Net Sales by Segments; 2020 (Percentage, %)
Figure 39: Stryker Corporation Net Sales by Region; 2020 (Percentage, %)
Figure 40: Johnson & Johnson Sales; 2016-2020 (US$ Billion)
Figure 41: Johnson & Johnson Sales by Segments; 2020 (Percentage, %)
Figure 42: Johnson & Johnson Sales by Region; 2020 (Percentage, %)
Table 1: The US Drug Eluting Sinus Stent (DESS) Market Players: A Financial Comparison; 2019/2020
Table 2: The US Drug Eluting Sinus Stent (DESS) Market Players by Products and Services
